Vol. 63, Issue 5, 2011September 01, 2011 EDT
The Forgotten Victim in the Human Gene Patenting Debate: Pharmaceutical Companies
The Forgotten Victim in the Human Gene Patenting Debate: Pharmaceutical Companies
Jacob D. Moore,
Articles in Vol. 63, Issue 5, 2011
Vol. 63, Issue 5, 2011
- Compensating Market Value Losses: Rethinking the Theory of Damages in a Market EconomySteven L. Schwarcz
- Multidimensional Governance and the BP Deepwater Horizon Oil SpillHari M. Osofsky
- Zoning Finality: Reconceptualizing Res Judicata Doctrine in Land Use CasesStewart E. SterkKimberly J. Brunelle
- Interrogation and the Roberts CourtJonathan Witmer-Rich
- Making BP’s Blood Curd-Le: Duty, Economic Loss, and the Potential Cardozian Nightmare after Curd v. Mosaic FertilizerBenjamin J. SteinbergDwayne Antonio Robinson
- The Forgotten Victim in the Human Gene Patenting Debate: Pharmaceutical CompaniesJacob D. Moore
Jacob D. Moore, The Forgotten Victim in the Human Gene Patenting Debate: Pharmaceutical Companies, 63 Fla. L. Rev. 1277 (2011).
